European Leukemia Trial Registry
Trial: RESPONSE

More Details
Title Study of INC424 in PV with Resistance to or Intolerance of Hydroxyurea
Scientific Title Randomized, Open Label, Multicenter Phase III Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 Tablets Versus Best Available Care
Short Title RESPONSE
Trialgroup NN
Type of Trial multicentric, randomized
Disease Myeloproliferative disease(MPD) Polycythaemia vera
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.10.2010
Contactperson

principal investigator
Reiter, Prof. Dr. med., Andreas
Tel: +49 (0)621 383 4158
Fax: +49 (0)621 383 4201
Email: andreas.reiter@uum.de

Shortprotocol Shortprotocol
created 13.12.2011 Johannes Kraus
changed 13.05.2013 Sina Hehn
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org